XML 35 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings (Loss) Per Share
 9 Months Ended
Nov. 30, 2025
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE
The following table sets forth the computation of basic and diluted earnings (loss) per share:
 Three Months EndedNine Months Ended
 November 30, 2025November 30, 2024November 30, 2025November 30, 2024
Net income (loss) from continuing operations for basic and diluted earnings (loss) per share available to common shareholders$13.7 $12.3 $28.9 $(0.7)
Net income (loss) for basic and diluted earnings (loss) per share available to common shareholders$13.7 $(10.5)$28.9 $(71.6)
Weighted average number of shares outstanding (000’s) - basic (1)
590,892 591,240 593,386 590,537 
Effect of dilutive securities (000’s)
Stock-based compensation (2) (3)
5,411 2,290 4,668 — 
Weighted average number of shares and assumed conversions (000’s) diluted596,303 593,530 598,054 590,537 
Earnings (loss) per share - reported
Basic earnings per share from continuing operations$0.02 $0.02 $0.05 $0.00 
Total earnings (loss) per share$0.02 $(0.02)$0.05 $(0.12)
Diluted earnings per share from continuing operations$0.02 $0.02 $0.05 $0.00 
Total diluted earnings (loss) per share$0.02 $(0.02)$0.05 $(0.12)
______________________________
(1) The Company has not presented the dilutive effect of the Notes using the if-converted method in the calculation of diluted earnings (loss) per share for the three and nine months ended November 30, 2025 and November 30, 2024, as to do so would be antidilutive. See Note 6 for details on the Notes.
(2) The Company has presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted earnings per share for the three and nine months ended November 30, 2025 and for the three months ended November 30, 2024.
(3) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the nine months ended November 30, 2024, as to do so would be antidilutive.